Michigan loses $3M on drug manufacturing try; API maker Croda buys a biotech firm;

> The University of Michigan expects to lose $120,000 next year, on top of $3.028 million this year, invested in an effort to get a Department of Defense contract to manufacture products at a former Pfizer ($PFE) site. Story

> A trade association in Africa says if countries there would invest more in research and development they would get better manufacturing as a side benefit. Article

> Chemicalmaker Croda has paid £5.9 million ($9.2 million) to buy the Italian biotech company Istituto di Ricerche Biotecnologiche and will merge it with its Sederma skin care business. Release

> Growth of 13% the unit that includes API sales at Albemarle helped buffer the overall 8% fall in revenue in the second quarter. Story

And Finally... The SME Pharma Industries Confederation (SPIC) in India is pushing the government even the tax burden for all contract manufacturing organizations, saying that those in tax-free zones are getting 70% of all contracts. Story

Suggested Articles

A biotech that worked with a nutritional products maker on the API for its clinical-stage radiation drug, is buying all of the manufacturing know-how.

Merck KGaA is selling a manufacturing site and its Allergopharma allergy drug business as it focuses on newer meds.

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S.